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Abstract: 
Objective: To characterize the structural and functional neurobiology of a large group of 
adolescents exhibiting a behaviorally and emotionally dysregulated phenotype.   
Method: Age 14 adolescents from the IMAGEN study were investigated. Latent class analysis 
(LCA) on the Strengths and Difficulties Questionnaire (SDQ) was used to identify a class of 
individuals with elevated behavioral and emotional difficulties (“dysregulated”; n=233) who 
were compared to a matched sample from a low symptom class (controls, n=233). Whole-brain 
gray matter volume (GMV) images were compared using a general linear model with 10,000 
random label permutations. Regional GMV findings were then probed for functional differences 
from three functional magnetic resonance imaging (fMRI) tasks. Significant brain features then 
informed mediation path models linking the likelihood of psychiatric disorders (DSM-IV) with 
dysregulation.  
Results: Whole-brain differences were found in the right orbitofrontal cortex (R.OFC; p<.05; 
k=48), with dysregulated individuals exhibiting lower GMV. The dysregulated group also 
exhibited higher activity in this region during successful inhibitory control (F1,429=7.53, p<.05). 
Path analyses indicated significant direct effects between the likelihood of psychopathologies 
and dysregulation. Modeling the R.OFC as a mediator returned modest partial effects, suggesting 
the path linking the likelihood of an anxiety or conduct disorder diagnoses to dysregulation is 
partially explained by this anatomical feature. 
Conclusion: A large sample of dysregulated adolescents exhibited lower GMV in the R.OFC 
relative to controls. Dysregulated individuals also exhibited higher regional activations when 
exercising inhibitory control at performance levels comparable to controls. These findings 
Blinded Manuscript - No Author Information
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 2 
suggest a neurobiological marker of dysregulation and highlight the role of the R.OFC in 
impaired emotional and behavioral control.  
Key words: dysregulation, SDQ, orbitofrontal cortex, adolescence, VBM 
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Introduction: 
 
 Adolescents exhibiting severe difficulties regulating behavior and emotion are commonly 
referred for psychiatric evaluation but are difficult to classify into discrete diagnostic categories, 
with “comorbidity” being the rule rather than the exception in child psychiatry. Previous labels 
for these dysregulated children included severe mood dysregulation (SMD) or irritability1 with 
the acknowledgement that these individuals will likely meet diagnostic criteria for other 
disorders. Recently, “disruptive mood dysregulation disorder” (DMDD)2 was added to the DSM-
5 to better classify dysregulated children. Research indicates the prevalence of dysregulation is 
between 0.8 and 3.3%, with particularly high co-occurrence with externalizing and internalizing 
disorders.3,4 As individuals with a singular diagnosis may be thought of as behaviorally or 
emotionally dysregulated, it is specifically the individuals with a set of difficulties spanning both 
behavioral and emotional domains who need to be studied further. Considering the addition of 
this disorder into the DSM, and research showing the functional outcomes of dysregulated youths 
are strikingly poor,5 it is imperative to identify the neurobiological correlates of dysregulation. 
Characterizing the pathophysiological substrates will help inform dysregulation nosology, 
provide diagnostic biomarkers, and help inform targeted treatment methods. 
 The NIMH recently advocated the Research Domain Criteria (RDoc), which hypothesizes 
psychiatric problems coexist on a spectrum of severity with symptoms that cut across discrete 
diagnostic categories. Therefore, in this report using a large dataset of adolescents (the IMAGEN 
study),6 we adopted a latent class analysis (LCA) approach to the Strengths and Difficulties 
Questionnaire (SDQ)7 to identify groups of individuals endorsing similar patterns of behavioral 
and emotional problems. The result of an SDQ-LCA provides class groupings, as well as 
dimensional characteristics of emotional and behavioral problems hypothesized to contain 
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 4 
varying patterns of symptomatology that resist discrete categorization. One class is specifically 
hypothesized to comprise a profile analogous to DMDD. In other words, in the absence of 
DMDD diagnoses, we hypothesized a class of individuals exhibiting a profile in line with a 
dysregulation phenotype. Although measurement of a dysregulation profile is a major challenge 
in the field,8–10 the intent of our investigation is to characterize the neural correlates of 
dysregulation as defined by one measurement method (among a suite of others).11,12  
 Structural neuroimaging, and specifically, voxel-based morphometry (VBM), has been 
used to study many psychiatric constructs across stages of development. VBM allows the 
researcher to measure the volumes of the major tissue types of the brain,13 thus providing a 
neurobiological framework to closely study a behavioral profile of interest. VBM has informed 
many adolescent psychiatric disorders related to dysregulation including anxiety,14 depression,15 
and conduct disorder.16 Regarding previous structural neuroimaging studies of dysregulation, 
Adleman and colleagues used VBM to uncover differences among children with SMD, bipolar 
disorder (BP), and controls, with the SMD group exhibiting the lowest gray matter volume 
(GMV) in bilateral pre-supplemental motor area, right insula and dorsolateral prefrontal cortex.17 
Additionally, Gold and colleagues used VBM to study youths with anxiety, BP, ADHD, and 
DMDD, compared to controls. Gold found GMV differences specific to, and across psychiatric 
disorders, with dysregulated participants exhibiting lower GMV in the right dorsolateral and 
superior frontal cortex.18 Therefore, for our primary analysis using whole-brain VBM data, we 
hypothesized dysregulated individuals would exhibit lower GMV relative to controls in cortical 
regions implicated in regulatory processes such as the bilateral insula, right-sided dorsolateral 
prefrontal cortex, and ventromedial/orbitofrontal cortex. 17,19 
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 Regions uncovered from the primary anatomical analysis can be used as regions of interest 
in post-hoc analyses on the fMRI data from the IMAGEN study. These post-hoc analyses 
broadly test the hypothesis that differences in brain structure yields differences in brain function. 
Interrogating both structure and function with the same dataset maximizes the information 
gained about the neurobiological characteristics of dysregulation, and captures the brain’s trait-
like features measured via structural neuroimaging, and state-like features measured during 
functional task demands. Follow-up analyses on neuroimaging data can also be used to explain 
the relationship between candidate comorbidity diagnoses3 and dysregulation. For instance, an 
identified neurobiological correlate of dysregulation can be modeled as a mediator in a path 
analysis linking the likelihood of a psychiatric disorder to dysregulation. In doing so, we test the 
hypothesis that the brain mediates the relationship between a disorder and dysregulation in some 
linear fashion. As we only probe data from the age 14 assessment of the IMAGEN study, these 
mediation models infer correlation and not causation. 
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Method: 
 Participants were drawn from the IMAGEN study of adolescent development.6 
Comprehensive study details are available in the online Standard Operating Procedures 
(https://imagen-europe.com/). The IMAGEN study conformed to the ethical standards outlined 
by the Declaration of Helsinki and was approved by ethics committees at each site including 
King’s College, London; Central Institute of Mental Health, Mannheim; Charite, 
Universitatsmedizin Berlin; University Medical Center Hamburg-Eppendorf; University of 
Nottingham; Trinity College Dublin; Institut National de la Sante et de la Recherche Medicale, 
Orsay. After description of the study to participants and their parents, written informed consent 
was obtained. Individuals who provided assent were assessed at age 14. For this report, all data 
were taken from the baseline assessment only (age 14).  Participants with SDQ data (N=2,126) 
were used as the starting sample of the analysis (Age M=14.56, SD=.44; Female individuals 
=1,081, 51%). Selected participants from the LCA analysis were then drawn from the sample 
who received an anatomical scan with GMV images passing quality control (N=2,024). 
 
Strengths and Difficulties Questionnaire 
 The SDQ is 25-item instrument designed to characterize children across five domains 
including emotional symptoms, conduct problems, hyperactive behavior, peer problems, and 
prosocial behaviors.7 Hence, the SDQ is especially suited to capture both the behavioral and 
emotional features related to dysregulation. Furthermore, the SDQ is widely used and has been 
shown to predict psychiatric diagnoses later in life.20 Data included in the analysis were from the 
parent reporting on their child’s behavior in the past six months. SDQ data from N=2,126 
participants were used in the latent class analysis. 
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 Each SDQ item is measured on an ordinal scale: 0=Not True, 1=Somewhat True, 
2=Certainly True. While the majority of the instrument is negatively valenced (e.g., “Often 
unhappy”, “Often lies or cheats”), the few positively valenced items are reversed coded with the 
exception of the entire prosocial domain. Therefore, higher values within the emotional, conduct, 
hyperactive or peer domain reflect difficulties, whereas higher values within the prosocial 
domain reflect strengths. For the input to the latent class analysis, positively valenced items from 
the prosocial domain were recoded to match the overall pattern of the instrument.  
 Previous investigators have reported using the SDQ-Dysregulation Profile (SDQ-DP) to 
measure the dysregulation construct based on the sum of five proposed items.21 Rather than 
imposing the recommended SDQ-DP cutoff of scores ≥5 as dysregulated, we used a data driven 
approach to characterize individuals based on patterns of similar problem behaviors. And while 
the SDQ-DP is based on five SDQ items spanning behavioral and affective problems, youths 
who score high on only the behavioral items may be categorized as dysregulated despite scoring 
low on the emotional items. The use of latent class analysis is hypothesized to overcome this 
limitation by identifying a class of individuals who are most likely to exhibit co-occurring 
behavioral and affective problems. Nonetheless, the SDQ-DP was calculated and compared to 
the class probabilities returned from the latent class analysis.  
 
Latent Class Analysis 
 Latent class analysis (LCA) is an example of a mixture model used to estimate group 
membership of latent constructs. LCA is robust to the categorical data format of the SDQ and 
assigns probability scores to each participant reflecting the likelihood of class membership. 
Participants were categorized into the class with the highest probability score.  
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 Latent class models were estimated using the software Mplus via an EM algorithm. Model 
comparison was performed on analyses returning 1-class through 7-class solutions. The best-
fitted model was identified using multiple measures of fit. The Bayesian Information Criterion 
(BIC) is a goodness-of-fit index that penalizes models with more classes. Lower BIC values 
indicate more parsimonious models. Because standard loglikelihood tests are biased in this 
analytic environment, two other examinations were used to compare a K class model to a K-1 
class model, the Vuong-Lo-Mendell-Rubin likelihood ratio test (VLMRT) and the bootstrap 
likelihood ratio test (BLRT). In each case, significance comparing a K class model to a K-1 class 
model indicates additional information is provided. If it is not significant, then the K-1 class 
model can be accepted. In addition, models with higher entropy (closer to 1) indicate a clearer 
delineation of classes.22 In this analysis, all indices other than the BLRT (which was not 
discriminating) indicated a 5-class model fit (see Table 1). These classes were then used to 
identify two groups of interest, a dysregulated group, and a low symptom comparison group 
(controls). Group identification was determined based on their respective patterns of item 
endorsement as further explained below.  
 
Structural Neuroimaging Methods 
 Across the eight acquisition sites, participants were scanned on 3T MRI scanners from 
various manufacturers (Phillips, General Electric, Bruker, and Siemens). Standardization and 
quality assurance efforts were made to insure all sites used the same MRI acquisition parameters 
and yielded comparable data. High-resolution anatomical magnetic resonance images were 
acquired, including a 3D T1-weighted magnetization prepared gradient echo sequence based on 
the ADNI protocol (http://adni.loni.usc.edu). The structural image was collected for nine minutes 
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 9 
using the following parameters: TR=2300ms; TE=2.8ms; flip angle=8o; matrix size=240x256; 
voxel resolution=1.1mm3; and 160 contiguous slices at a thickness of 1.1mm. 
 Whole-brain gray matter volume (GMV) images were generated using optimized voxel-
based morphometry procedures in SPM8.13 High-resolution anatomical magnetic resonance 
images were acquired, including a 3D T1-weighted magnetization prepared gradient echo 
sequence based on the ADNI protocol (http://adni.loni.usc.edu). Structural MRI preprocessing 
included segmenting and normalizing the images into Montreal Neurological Institute template 
space. The gray matter segmentation images were then modulated to obtain volumetric images, 
rather than tissue concentration images. N=2,024 participants received a structural MRI and had 
GMV images passing quality control.  
 In preparation for the between-group GMV comparison, variables potentially influencing 
adolescent GMV (age, sex, site of imaging acquisition, handedness, puberty status,23 verbal and 
performance IQ,24 and total GMV) were partialled out of the images. To do so, all participants 
from the baseline IMAGEN sample with preprocessed GMV images (N=2,024) were submitted 
to a multiple regression with only the confounding variables included in the design matrix. The 
residual GMV image for each participant was then used in the permutation test described below. 
This procedure was used because including nuisance covariates in the permutation analysis 
prohibitively increased computation time.  
 In light of recent criticisms related to the proper correction for multiple comparisons in 
neuroimaging research,25 permutation analyses have been advocated as a non-parametric 
approach to closely control the number of false-positives in a statistical analysis.26 Here, we used 
a random label permutation test applied to the residual output of the aforementioned nuisance 
regression. Each participant’s group membership was randomly shuffled and a whole-brain two-
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group t-test using a general linear model was fitted to the residualized images. Random label 
shuffling was repeated 10,000 times, thus building a null distribution at each voxel, to which the 
originally labeled results were compared. Threshold-free cluster enhancement correction 
(TFCE)27 was then used to control the family-wise error rate for identifying clusters of residual 
gray matter that exhibit significant group differences. Regions of interest (ROI) surviving a 
TFCE corrected α < .05 were then probed for fMRI group differences, as well as being modeled 
as the mediator in candidate path analyses linking the likelihood of psychopathology to 
dysregulation. Permutation analyses were conducted using FSL’s Permutation Analysis of Linear 
Models26 on the University of Vermont’s Advanced Computing Core.  
 
Functional Neuroimaging Methods 
 Three fMRI tasks commonly used in psychiatric neuroimaging were administered, 
including the stop signal task, monetary-incentive delay task, and a face-processing task. The 
stop signal (inhibitory control) task requires participants to inhibit a prepotent motor response.28 
Motor inhibitory control performance during this task is commonly measured using the stop 
signal reaction time (SSRT), an estimate of the speed of the inhibitory process, calculated from 
the average latency period between the “go” and “stop signal” during successful inhibition 
trials.29 The monetary-incentive delay task measures the processing of both anticipation and 
receipt of monetary rewards.30 The face-processing task involves the passive viewing of angry 
faces, neutral faces, and control images.31 See Supplement 1, available online, for full details on 
the fMRI tasks. 
 All fMRI data were submitted to standard preprocessing methods and whole-brain contrast 
images specific to each task were estimated using a general linear model (see Supplement 1, 
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available online, for fMRI processing details). Specifically, unsuccessful and successful 
inhibitory control, monetary reward anticipation and receipt, angry faces, neutral faces, and the 
differential activation for angry minus neutral faces, were each used to explore any functional 
differences between the groups. For each contrast image, the mean value within a region of 
interest (ROI) was extracted and analyzed using two-group ANCOVA models with a Bonferroni 
corrected alpha based on the number of contrasts tested for each task modality. 
 
Likelihood of Psychiatric Diagnoses 
 Psychopathology was determined using the Developmental and Well-Being Assessment 
(DAWBA; http://www.dawba.info/a0.html), a set of computer-administered interviews, 
questionnaires, and ratings generating DSM-IV psychiatric diagnoses for ages 5-17. Based on the 
child and parent responses, a computer algorithm generates scores to predict the likelihood of 
meeting criteria for DSM-IV diagnoses (“band scores”). These band scores range from 1 to 5, 
representing a probability of <0.1% to >70%. DAWBA band scores have been shown to yield 
prevalence estimates that broadly compare to clinician-rated diagnoses.20  
 
Mediation Analyses 
 Mediation was conducted in Mplus using a robust weighted least squares estimator to 
estimate direct and indirect effects, with bias-corrected 95% confidence intervals generated from 
1000 bootstrapped samples. The use of bootstrapping the indirect effects is a more powerful 
method of inferring mediation compared to the traditional five-step procedure.32 The independent 
variables for the five separate mediation analyses included the full range of DAWBA band 
scores, representing the likelihood of receiving a DSM-IV diagnosis for anxiety, depression, 
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conduct disorder (CD), oppositional defiance disorder (ODD), and attention deficit hyperactivity 
disorder (ADHD). These five constructs were informed by Copeland and colleagues who 
assessed the prevalence rates of DMDD comorbidity with these disorders.3 Furthermore, these 
disorders broadly capture the co-occurring internalizing and externalizing problems exhibited by 
dysregulated individuals.  
 The identified GMV features were modeled as a mediator between each band score and 
the binary dysregulation status as the dependent variable. Hence, models were constructed to test 
the hypothesis that the underlying neurobiology influences the relationship between a related 
psychiatric disorder and the dysregulated phenotype. As the initial neuroimaging analysis here 
tests for a biomarker of dysregulation in isolation, follow up path analyses assessed the 
involvement of brain structure with dysregulation in the context of affiliated psychiatric 
diagnoses reported by Copeland and colleagues. Any significant indirect effects uncovered by 
these path models provides evidence indicating the correlation between the likelihood of a 
related disorder and being dysregulated is driven, in part, through changes in focal brain 
structure.  
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Results: 
 
Latent Class Analysis Results 
 The best-fitting LCA model returned a five-class solution (see Table 1 for fit statistics). 
Here, we describe each class and offer a label to characterize their profile. Class 1, the “defiant 
class” (18% of the sample), contained individuals with low prosocial traits and slightly elevated 
conduct problems and hyperactivity. Class 2, the “emotional difficulties” class (16% of the 
sample), contained individuals with the highest emotional difficulties. Class 3, the “dysregulated 
class” (12% of the sample), contained individuals with very high levels of difficulties across all 
five domains. Class 4, the “hyperactive class” (25% of the sample), contained individuals with 
elevated hyperactivity. Class 5, the “low symptom class” (29% of the sample), contained 
individuals with very low levels of problem behaviors across all domains. And while class 5 is 
labeled “low symptoms”, we note that the defiant, emotional difficulties, and hyperactive classes 
also exhibit low symptoms on domains outside of their problem areas. These findings are 
consistent with studies reporting high prevalence rates of any level of psychiatric 
symptomatology in adolescence.33 See Figure 1 for the average item-endorsement for each class 
and Table 2 for the five SDQ summary scores for each class. 
 While other classes exhibited elevations in a single domain (i.e., emotional difficulties 
class; hyperactive class), the dysregulated class distinctly exhibited co-occurring behavioral and 
affective problems. These individuals exhibited the highest probability of endorsing conduct 
problems, hyperactivity, peer problems, and the second highest probability of endorsing 
emotional problems (closely following the emotional difficulties class), and prosocial problems 
(closely following the defiant class). The low symptom class (the largest sample) was selected as 
the comparison group as they exhibited the lowest probability of endorsing all problematic 
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behaviors. See Table S1, available online, for comparison of the dysregulated class to the full 
sample on descriptive characteristics. 
 Next, the SDQ-DP was calculated to compare to the LCA results using bivariate 
correlations between the SDQ-DP sum score and the probability of each class membership. 
Results indicated the SDQ-DP was most positively associated with the dysregulated class (r2126 = 
.61, p<.001) and most negatively associated with the low symptom class (r2126 = -.44, p <.001), 
thus providing support for the dysregulated phenotype captured by class 3 and the low symptom 
group captured by class 5.  However, these correlations may be inflated as both measures were 
estimated from similar items on the same dataset. Nonetheless, Holtmann and colleagues report 
correlations between their SDQ-DP and Child Behavior Checklist-Dysregulation Profile (CBCL-
DP) binary score at r=.45 and CBCL-DP sum score at r=.75. Therefore, the LCA results reported 
here are in line with these other measurement instruments.  
 There were 184 participants included in the LCA who did not provide anatomical scan 
data (for reasons including failing quality control, MRI safety issues, etc.). However, chi-square 
tests indicated there was no difference in LCA class membership in this subsample relative to the 
larger sample with anatomical scan data (Χ24,2126  = 2.2 , p > .05). Thus, we do not believe there 
was any skew in the LCA class assignment by the participants who did not provide anatomical 
scan data. 
 
Neuroimaging Sample Characteristics 
 Of the 261 dysregulated and 613 low symptom comparison individuals identified from the 
LCA, 233 dysregulated and 564 comparison individuals provided useable GMV data. For the 
sample of 233 dysregulated individuals, an equal size subset of comparison individuals was 
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selected from the low symptom class. This control group was pseudo-randomly selected so as to 
match to the dysregulated group by containing an equal number of male and female individuals 
who showed no differences on total GMV, pubertal development, performance and verbal IQ, or 
age, and contained similar distributions for handedness and site of acquisition (see Table S2, 
available online, for group comparisons). And while site was included in the initial nuisance 
regression of the full IMAGEN dataset, it is difficult to precisely account for site when there are 
unequal representations at each site. Hence, a pseudo-random sampling of the two groups was 
performed to identify a subsample of individuals with equal representations at each site. Results 
using this perfectly site-matched subsample were consistent with the main findings reported 
below. See Supplement 1, available online, for more information.  
 
Whole-brain Residual Gray Matter Volume Comparison 
 After running a two-sample t-test using a general linear model with 10,000 random label 
permutations, a single cluster survived TFCE-correction for multiple comparisons (PFWE-corr<.05, 
k=48 voxels). This cluster was found in the right orbitofrontal cortex (OFC), center of mass at 
(MNI: 24, 30, -16), spanning the orbital sulcus with extent into the posterior orbital gyrus. In this 
region, dysregulated individuals exhibited lower residual GMV relative to their peers with low 
symptoms (see Figure 2).  
 
Laterality Test 
 As only one hemisphere survived strict correction, and there is growing interest in 
prefrontal asymmetry, a contralateral region of interest analysis was performed post-hoc. To 
perform this test, we translated the right-sided region of interest onto the left hemisphere and 
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extracted regional GMV for all subjects. Two-sample t-tests indicated the left OFC ROI yielded 
significant differences (L.OFC: t462 = -3.32, p < 1.0x10-3), similar to the findings in the right 
OFC, albeit at a relatively lower magnitude of effect (R.OFC: t462 = -4.40, p < 1x10-4).  
  
fMRI Comparisons 
  The identified sample for GMV analyses (n=466) was selected on the basis of the quality 
of their anatomical image, meaning some of these participants did not have fMRI data available. 
See Table S3 and Supplement 1, available online, for full details regarding these reduced 
samples, and reasons for missingness. In preparation for the ROI-level between-group 
comparisons using the fMRI data, we first examined the amount of head motion in the images. 
For each subject, the mean framewise displacement (mean FD) was calculated for each of the 
three fMRI tasks. Based on prior developmental neuroimaging studies,34 a head motion 
exclusionary criterion of mean FD > .9mm was used. For the stop signal task, 3 dysregulated 
participants were excluded. For the faces task, 1 dysregulated participant was excluded. For the 
MID task, 5 dysregulated and 1 low symptom participants were excluded. Importantly, these 
reduced samples for fMRI comparisons retained critical between-group similarities as the 
starting samples for anatomical comparisons. Chi-square (for categorical measures) and t-tests 
indicated that after excluding subjects, the reduced samples retained their best-matched 
characteristics and did not differ on age, sex, handedness, IQs, or total GMV (p > .05).  
 Data were then submitted to standard two-sample t-tests to determine any group 
differences in head motion for a given task. Results indicated that while mean FD did not exceed 
thresholds previously reported as problematic,35,36 the dysregulated sample exhibited 
significantly more head motion during each fMRI acquisition (see Table S4, available online). 
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Although participants’ head motion parameters were included in the design matrix during their 
fMRI contrast estimation, we also included mean FD as a covariate in the ROI-level between-
group ANCOVA models.    
 For the stop signal task, results indicated a significant between-group difference during 
successful inhibitory control trials F1,377=5.61, pcorr<.05, such that the dysregulated group showed 
higher activation (n=186, M=.15, SD=1.2) than the low symptom group (n=194, M=-.09, 
SD=.92). To ensure these findings were not driven by the difference in head motion, similar 
ANCOVA models were estimated on 5,000 pseudo-random subsamples of the data matched on 
head motion. Results were consistent, leading to a mean F1,307=4.9, p<.05, suggesting the 
between-group difference on successful inhibitory control activations were not driven by head 
motion. See Supplement 1, available online, for more information.  
 Due to problems with the behavioral task performance adaptive algorithm, stop signal 
reaction time (SSRT) scores were available on only a subset of participants. A between-group 
comparison on those individuals with useable SSRT behavioral data (Dysregulated n=97; 
Controls n=107) yielded no significant differences on SSRT (t202=0.38, p = .71). Given the 
reduced sample sizes of participants with SSRT data, no imputations were performed for SSRT, 
and it is unknown the degree to which the effects might generalize to the starting samples. No 
between-group activation differences were detected for unsuccessful inhibitory control trials, or 
on any of the remaining fMRI contrasts (reward and face processing tasks).  
  
Mediation Analyses 
 The likelihood of having any of the five psychopathologies exhibited a significant total 
and direct effect with dysregulation, substantiating their relationship with dysregulation.3 Bias-
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corrected confidence intervals around the indirect effect of the right OFC GMV ROI indicated 
this region partially mediated the likelihood of an anxiety disorder diagnosis (c=.023, 95% CI 
[0.003, 0.043]) or conduct disorder diagnosis (c=.018, 95% CI [.003, .033]) to dysregulation 
status (see Figure 3). No significant indirect effects were detected to link the brain between the 
likelihood of depression, ODD, or ADHD with dysregulation. Additionally, regional fMRI brain 
activation during successful inhibitory control did not yield any significant mediation effects.  
See Table 3 for mediation model results.  
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Discussion: 
 
 We report that emotionally and behaviorally dysregulated adolescents exhibited lower 
GMV in the right OFC relative to their non-dysregulated peers. These findings were identified 
by a conservative permutation analysis between two large samples of closely matched groups. 
Secondary analyses indicated that within this same region, the dysregulated group exhibited 
higher functional brain activation when executing successful inhibitory control behaviors. These 
fMRI results provide some specificity on the psychological correlates of the GMV effect, such 
that the anatomical difference associated with dysregulation was related to inhibitory control but 
not to face or reward processing. Taken together, these results suggest dysregulation is 
characterized by differences in cortical regions involved with executive functioning. Lastly, the 
volume of the right OFC region partially mediated relationships between the likelihoods of an 
anxiety disorder and a conduct disorder diagnosis and dysregulation.  
 It is interesting that the right OFC was uncovered from a conservative whole-brain 
analysis and also exhibited differences on the stop signal task, as there is a body of research 
implicating the OFC in behavioral and emotional regulation. For example, previous research on 
the IMAGEN sample identified this region as participating in a network of brain activity during 
successful inhibitory control trials.37 As the dysregulated and low symptoms groups exhibited 
similar task performance, the greater activity in the right OFC of the dysregulated group may 
reflect greater effort or cognitive resources needed to execute inhibitory behaviors equal to that 
of their peers. Therefore, dysregulation may be partly dependent on a neurobiological inhibitory 
control network compromised in its ability to efficiently regulate behavior.  
 The OFC is also putatively involved in integrating attention and emotion by assigning a 
signal of affective value to stimuli. Previous work using event-related potentials (ERP) during an 
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affective go/no-go task was conducted on children with co-occuring internalizing and 
externalizing disorders.  One set of results identified higher ventral prefrontal activations during 
inhibitory control trials in children with poor self-regulatory abilities as measured via parent-
child observations.38 In a related treatment study of similar children, treatment success was 
characterized by attenuation of activation levels in the ventral prefrontal region during inhibitory 
control trials.39 Hence, our findings are in line with these reports and suggest the OFC as both a 
potential biomarker and candidate region for targeted clinical interventions to help improve 
outcomes in children with dysregulated behavioral profiles.  
 In terms of the mediation results, the investigated psychopathologies all exhibited a 
significant and large total effect on dysregulation, indicating that the likelihood of having an 
internalizing or externalizing disorder was associated with an increased likelihood of being 
dysregulated. These findings are consistent with previous reports identifying similar patterns of 
comorbidity from three datasets of child psychopathology.3 Moreover, the direct effects were 
also large, accounting for nearly 98% of the total effect for all disorders (see Table 3). Given 
these relationships, the significant partial mediation results are notable as little variance is left to 
be explained by the indirect paths. Yet despite these relatively weak indirect effects, the 
significant findings highlight the transdiagnostic nature of the right OFC region insofar as it is a 
mediator to dysregulation for the likelihood of anxiety and conduct disorder. Although a 
significant mediation was not observed for depression, ODD, or ADHD it would be incautious to 
conclude that the mediation effect has specificity for anxiety and conduct disorder as effects in 
similar directions were observed for depression (p=.065) and ODD (p=.070; see Table 3). On the 
whole, the data suggest a small but potentially important role for the OFC in linking internalizing 
and externalizing disorder to dysregulation. Lastly, we reiterate the path models should not be 
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misinterpreted as implying the likelihood of an anxiety, conduct disorder, or the brain feature 
caused dysregulation as the models are restricted to age 14 data only. 
 Limitations of this study include the lack of DSM-5 diagnostic measures, as it is unclear if 
the individuals contained in the dysregulation group meet DMDD diagnostic criteria. Future 
studies are needed to evaluate the degree to which the SDQ captures individuals who receive a 
DSM-5 DMDD diagnosis following a clinical interview. Likewise, measurement studies are also 
needed to determine the correlation between popular measurement methods like SDQ-LCA, 
SDQ-DP and CBCL-DP, and their correlation with clinical ratings. Additionally, recent work 
taking a factor analytic approach to the SDQ has identified a dysregulation factor using just three 
of the five domains, omitting the prosocial and peer problem domains.10 However, given that 
elevations in the CBCL Social Problems domain frequently accompany the CBCL-DP,8 this 
approach risks omitting relevant features of the dysregulation construct.  
 In considering dysregulation measurement inconsistencies, differences in the precise brain 
region uncovered here with the previous regions uncovered by Adleman and by Gold and 
colleagues are likely attributed to differing measurement approaches. Nonetheless, the right-
sided prefrontal anatomical finding is broadly consistent with these prior results. Although 
earlier fMRI studies of inhibitory control in dysregulation failed to detect significant group 
differences41 this is likely due to our fMRI analysis, by design, being restricted to a single 
anatomically defined region of interest. Another important consideration in interpreting the 
present fMRI results and integrating them with past findings is the potential confounding role of 
head motion. Despite including mean framewise displacement as a covariate, ANCOVA models 
are generally unable to completely control for a significant between-group difference in that 
covariate. Confidence in our results comes from the 5,000 pseudo-random subsampling 
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procedure in which the group differences were recapitulated with subsamples chosen not to 
differ on head motion.  
 A caveat regarding the mediation results is that the path models were estimated using 
DAWBA band scores. As the DAWBA contains many skip rules leading some participants to 
“screen in” for extra items, these skips rules are sometimes related to high SDQ domain scores. 
Estimating paths between band scores and a binary dysregulation score determined via an SDQ-
LCA consequently may contain a degree of circularity. Another limitation of the present study is 
the use of single informant data, although previous studies suggest agreements among multi-
informants are generally low.42 Finally, given the neurodevelopmental changes underway at age 
14, it is unknown if the neuroanatomical difference identified here persists throughout the 
lifespan. Future longitudinal studies on dysregulated individuals are needed to determine the 
psychosocial and neurobiological antecedents of dysregulation, as well as the developmental 
effect of neural maturation on the persistence of dysregulation into late adolescence and 
adulthood.  
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Table 1: Latent Class Analysis Model Fit Statistics 
 
 
 
Number of 
Classes 
 
Fit Statistics 
 
-2 
loglikelihood 
 
BIC 
 
VLMR 
 
BLRT 
 
Entropy 
1 -39030.3 78443.79 NA NA 1 
2 -36850.3 74474.39 <0.001 <0.001 0.82 
3 -36188.3 73541.19 <0.001 <0.001 0.80 
4 -35664.2 72883.75 0.0046 <0.001 0.79 
5 -35252 72450.08 0.0028 <0.001 0.81 
6 -35067.2 72471.34 0.3346 <0.001 0.81 
7 -34893.2 72514.15 0.7601 <0.001 0.81 
 
Note: BIC = Bayesian Information Criterion; BLRT = Bootstrap Likelihood Ratio Test; NA = 
not applicable; VLMR = Vuong-Lo-Mendell-Rubin Likelihood Ratio. 
 
 
 
 
 
 
 
 
 
Table 2: Strengths and Difficulties Questionnaire (SDQ) Summary Scores For Each Latent Class 
 
 
 
 
 
 
 
 
 
 
 
Note: Class 3 comprised the “dysregulated” group who exhibited highest levels of impairment 
across all dimensions. Class 5 comprised the “low symptom” control group who exhibited the 
lowest levels of impairment. Summary scores were calculated by the sum of five items related to 
each dimension.7 Higher values signify more difficulty except within the prosocial domain.  
 
 
 
 
 
 
Class (N) 
SDQ Summary Scores 
Emotional 
Symptoms 
(M, SD) 
Conduct 
Problems 
(M, SD) 
Hyperactive 
Behavior 
(M, SD) 
Peer 
Problems 
(M, SD) 
Prosocial 
Behavior 
(M, SD) 
1 (373) 1.36, 1.30 1.98, 1.29 2.52, 1.51 1.66, 1.57 5.81, 1.36 
2 (340) 4.20, 1.76 1.37, 1.19 3.16, 1.84 2.51, 1.71 8.99, 1.02 
3 (261) 4.15, 2.23 4.32, 1.58 6.44, 1.98 2.91, 2.08 6.31, 1.97 
4 (539) 1.20, 1.10 1.57, 1.17 3.99, 1.43 0.57, 0.80 8.59, 1.02 
5 (613) 0.88, 1.05 0.64, 0.83 0.81, 0.87 0.89, 1.07 9.04, 1.03 
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Table 3: Summary of Mediation Models 
 
Note: Total effects reflect association between the likelihood of disorder and dysregulation. 
Direct effects reflect the association between the likelihood of a disorder and dysregulation while 
accounting for the gray matter volume (GMV) region of interest (mediator). Indirect effects are 
the difference in betas, and reflect the magnitude of mediation through the region of interest. 
Significant indirect effects (95%CI >0) in bold. ADHD = attention-deficit/hyperactivity disorder; 
ODD = Oppositional Defiant Disorder; SE = standard error.   
 
Model 
 
B 
 
SE 
 
p 
95% Bootstrapped 
CI 
    Lower Upper 
      
Anxiety to Dysregulation      
Total Effect .690 .055 .001 .582 .799 
Direct Effect .667 .058 .001 .554 .780 
Indirect Effect .023 .010 .025 .003 .043 
 
Depression to Dysregulation      
Total Effect .700 .044 .001 .613 .788 
Direct Effect .683 .045 .001 .595 .772 
Indirect Effect .017 .009 .065 -.001 .035 
 
 
Conduct Disorder to Dysregulation      
Total Effect .780 .035 .001 .712 .848 
Direct Effect .762 .036 .001 .692 .833 
Indirect Effect .018 .008 .022 .003 .033 
 
ODD to Dysregulation      
Total Effect .841 .024 .001 .794 .888 
Direct Effect .826 .025 .001 .776 .876 
Indirect Effect .015 .008 .070 -.001 .031 
 
ADHD to Dysregulation       
Total Effect .919 .019 .001 .882 .957 
Direct Effect .909 .021 .001 .867 .951 
Indirect Effect .010 .006 .124 -.003 .023 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 31 
Figure Titles and Captions 
 
Figure 1: Average Strengths and Difficulties Questionnaire (SDQ) Item Endorsement for Five 
Classes 
 
Note: Each SDQ item present on the x-axis, ordered by the five respective SDQ domains to aid 
in interpretability. Average item endorsement on y-axis, from 0-2 (Not true, somewhat true, 
certainly true). Items with asterisks indicate reverse coding. Dysregulated class (3) in green line; 
low symptom class (5) in black line. 
 
Figure 2: Right Orbitofrontal Cortex Region of Interest 
 
Note: Cluster (k=48 voxels; center of mass Montreal Neurological Institute (MNI) coordinates: 
3), identified as passing TFCE-correction (p < .05) from a two-sample residual gray matter 
volume permutation analysis. This cluster was also present in a two-group permutation analysis 
estimated without residualized images or nuisance covariates. TFCE = Threshold-Free Cluster 
Enhancement.27  
 
Figure 3: Mediation Models with Significant Indirect Effects 
 
Note: Path models of the relationship between the likelihood of anxiety disorder (left), or, 
conduct disorder (right), to dysregulation, mediated by the right orbitofrontal cortex gray matter 
volume region of interest (ROI). All coefficients are standardized and pass a null-hypothesis 
significance test at p<.05. The indirect effects (dotted line, c paths) reflect the magnitude of 
mediation through the ROI, with significance determined by 95% confidence intervals generated 
from 1000 bootstrapped samples (see Table 3). Total effects (c’ paths) reflect the bivariate 
correlation between a disorder and dysregulation when the mediator is excluded. The negative 
parameter estimates for the paths into and out of the ROI (a and b paths) are in line with the 
lower gray matter volume (GMV) exhibited by the dysregulated group. OFC = orbitofrontal 
cortex.  
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Supplemental 1 
Materials and Methods 
Structural MRI  
High-resolution anatomical magnetic resonance images were acquired, including a 3D 
T1-weighted magnetization prepared gradient echo sequence based on the ADNI protocol 
(http://adni.loni.usc.edu). Structural MRI processing included data segmentation and 
normalization to the Montreal Neurological Institute template using the SPM optimized 
normalization routine. Gray matter images were modulated, thus facilitating comparisons of 
volumetric, rather than tissue concentration, differences.1 N=2095 participants had data 
submitted to the morphometric processing pipeline.  
Functional MRI  
Full details of the magnetic resonance imaging (MRI) acquisition protocols and quality 
checks have been described previously, including an extensive period of standardization across 
MRI scanners.2 MRI Acquisition Scanning was performed at the eight IMAGEN assessment 
sites (London, Nottingham, Dublin, Mannheim, Dresden, Berlin, Hamburg, and Paris) with 3T 
whole body MRI systems made by several manufacturers (Siemens: 4 sites, Philips: 2 sites, 
General Electric: 1 site, and Bruker: 1 site). To ensure a comparison of MRI data acquired on 
these different scanners, we implemented image acquisition techniques using a set of parameters 
compatible with all scanners that were held constant across sites, for example, those directly 
affecting image contrast or fMRI preprocessing.  
 For each task the following MRI acquisition parameters were used. 300 whole-brain 
volumes were collected using a gradient-echo T2*-weighted pulse sequence (EPI), with a 
TR=2,200ms, TE=30ms, matrix size=64x64; voxel resolution=3.4mm, with 40 slices collected in 
Supplemental Materials (Online Only)
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descending order at a thickness of 2.4mm with 1mm spacing gap. The field of view was set 
parallel to the AC-PC line to minimize signal dropout.  
Standardized hardware for visual and auditory stimulus presentation (NordicNeurolabs, 
Bergen Norway, http://www.nordicneurolab.com) was used at all sites. BOLD functional images 
were acquired with a gradient-echo echo planar imaging (EPI) sequence using a relatively short 
echo-time to optimize imaging of subcortical areas. Briefly, the functional imaging processing 
was as follows: Time series data were first corrected for slice-timing, then corrected for 
movement, non-linearly warped onto MNI space using a custom EPI template, and Gaussian-
smoothed at 5mm-full width half maximum. Nuisance variables were also added to the design 
matrix: estimated movement was added in the form of 12 additional regressors (3 translations, 3 
rotations, 3 translations shifted 1 TR before and 3 translations shifted 1 TR later). Each 
individual fMRI time series underwent automatic spike detection, using a mean-squared based 
metric to identify unexpected values temporally and spatially slice per slice. Time-points with 
artifacts (if any) of each sequence were regressed out of each participant’s data by adding a 
corresponding number of regressors with value 1 at the time- point of the artifact and 0 
elsewhere to the design matrix.  
From the N=2024, with structural MRI data, there were n=1807 with stop task data, 
n=1814 with reward task data, and n=1889 with faces task data. Variability across fMRI sample 
sizes are due to many reasons, including but not limited to data quality control, technical errors 
during scanning, poor task performance, and incomplete scanning sessions. 
Functional Tasks Information  
Stop Signal Task (SST)  
The SST required volunteers to respond to regularly presented visual go stimuli (arrows 
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pointing left or right) but to withhold their motor response when the go stimulus was followed 
unpredictably by a stop-signal (an arrow pointing upwards). Stopping difficulty was manipulated 
across trials by varying the delay between the onset of the go arrow and the stop arrow (stop-
signal delay, SSD) using a previously described tracking algorithm.3 A block contained 400 go 
trials and 80 variable delay stop trials with between 3 and 7 go trials between two stop trials. 
Stimulus duration in go trials was 1000 ms and in stop trials varied (0– 900ms in 50 ms steps) in 
accordance with the tracking algorithm (initial delay = 250 ms). We calculated contrast images 
for successful inhibitions (“stop success”) and unsuccessful inhibitions (“stop fail”), both vs. an 
implicit baseline.  Behavioral data from the stop signal task was incomplete due to technical 
errors, therefore this data was omitted from the modeling procedures, however, the stop signal 
task had an adaptive performance algorithm to account for individual differences in reaction 
time.  
Monetary Incentive Delay (Reward Task) 
The Monetary Incentive Delay (MID) task (adapted from a task described previously)4 
required participants to respond to a briefly presented target by pressing either a left-hand or 
right-hand button as quickly as possible to indicate whether the target appeared on the left or the 
right side of the monitor display. If the participants responded while the target was on the screen, 
they scored points but if they responded before the target appeared or after the offset of the target 
they received no points. A cue preceded the onset of each trial, reliably indicating the position of 
the target and the number of points awarded for a successful response. A triangle indicated no 
points (No Win), a circle with one line 2 points (Small Win) and a circle with three lines 10 
points (Large Win). Twenty-two trials of each type were presented in a pseudo-random order. 
The duration of the target was adjusted adaptively so that 66% of the trials produced a correct 
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response. The participants were informed that at the end of the session they would receive one 
candy (M&M) for every five points won. We calculated contrast images for the anticipation 
period of Large Win minus No Win, and the outcome period for Large Win minus No Win.  
Face Processing Task  
The Face task involved passive viewing of video clips that displayed ambiguous 
(emotionally ‘‘neutral’’) or angry face expressions or control (nonbiological motion) stimuli.5 
Each trial consisted of short (2 to 5 s) black-and-white video clips depicting either a face in 
movement or the control stimulus. The control stimuli consisted of black-and-white concentric 
circles of various contrasts, expanding and contracting at various speeds, roughly matching the 
contrast and motion characteristics of the face clips. The stimuli were presented through goggles 
(Nordic Neurolabs, Bergen, Norway) in the scanner and subtended a visual angle of 10ο by 7ο. 
The video clips were arranged into 18-s blocks; each block included seven to eight video clips. 
Five blocks of each biological-motion condition (neutral and angry faces), and nine blocks of the 
control condition (circles) were intermixed and presented to the participant in a 6-minute run. 
We calculated contrast images from angry faces minus control stimuli, neutral faces minus 
control stimuli, and angry faces minus neutral faces. After the scanning session, participants 
completed a recognition task in which they were presented with three of the faces previously 
presented in the scanning session and two novel faces.  
Head Motion  
Head motion estimates were included as nuisance regressors twice— once during first 
level task activation analyses (12 regressors: 3 translation, 3 rotation, 3 translations shifted 1 TR 
before, and 3 translations shifted 1 TR later), and again during the between group ANCOVA 
models (mean framewise displacement). The framewise displacement (FD) for each participant 
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for each fMRI task was calculated using the six displacement parameters estimated during image 
realignment preprocessing procedures.6 Based off prior developmental neuroimaging studies, a 
head motion exclusionary criterion of mean FD > .9mm was used.7 For the stop signal task, 3 
dysregulated participants were excluded. For the faces task, 1 dysregulated participant was 
excluded. For the MID task, 5 dysregulated and 1 low symptom participants were excluded. 
After applying this exclusion, mean FD for each subject for each task was then submitted to a 2-
sample t-test to determine if head motion across each task significantly differed between the two 
groups. While mean FD was generally low for each group, there was still significantly greater 
head motion in the dysregulated group. See supplemental table 4 for results.  
 Additionally, we tested the hypothesis that head motion is associated with dysregulation 
status by running a correlation between the dysregulated class probability score (class 3 from the 
LCA) with the mean framewise displacement for each task. As expected, modest correlations 
were detected, suggesting that a higher probability of dysregulation class membership is 
associated with more head motion during the stop task (r=.149, p<.005), faces task (r=.141, 
p<.005), and MID task (r=.146, p<.005).  As stated, this effect is expected as the two groups are 
known to exhibit between-group differences in head motion.  
 
Characterizing Instruments 
Wechsler Intelligence Scale for Children.  
Participants completed a version of the Wechsler Intelligence Scale for Children WISC-
IV,8 of which we included the following subscales. Perceptual Reasoning, consisting of Block 
Design (arranging bi-colored blocks to duplicate a printed image) and Matrix Reasoning (in 
which a series of colored matrices are presented and the child is asked to select the consistent 
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pattern from a range of options). Verbal Comprehension consisting of Similarities (two similar 
but different objects or concepts are presented and the child is asked to explain how they are 
alike or different) and Vocabulary (a picture is presented or a word is spoken aloud by the 
experimenter and the child is asked to provide the name of the depicted object or to define the 
word).  
Puberty Development Scale.  
The Puberty Development Scale (PDS)9 was used to assess the pubertal status of each 
participant. This scale provides an eight-item self-report measure of physical development based 
on the Tanner stages with separate forms for males and females. For this scale, there are five 
categories of pubertal status: 1= prepubertal, 2=beginning pubertal, 3=midpubertal, 4=advanced 
pubertal, 5=postpubertal. Participants answered questions about their growth in stature and pubic 
hair, as well as menarche in females and voice changes in males.  
 
Missing Data 
Dysregulated Group Missingness 
From the starting N=233 dysregulated participants with an anatomical scan, 226 received 
a stop signal task scan. The reasons for missingness in those seven are unknown but are likely 
due to the participant electing to stop, scheduling conflicts, or scanner malfunctions. Of those 
226, there were three participants excluded due to excessive head motion. Of the remaining 223, 
there were 37 participants who did not provide stop success images, and, 28 participants who did 
not provide stop failure images. Reasons for missing these contrast images may be due to any 
combination of reasons including poor task performance, technical errors, or poor image quality. 
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Hence, for the dysregulated group there were 186 participants with stop success images and 195 
participants with stop failure images. 
From the starting N=233 dysregulated participants with an anatomical scan, 222 received 
a reward task scan. The reasons for missingness in those 11 are unknown but are likely due to the 
participant electing to stop, scheduling conflicts, or scanner malfunctions. Of those 222, there 
were five participants excluded due to excessive head motion. Of the remaining 217, there were 
22 who did not provide either reward anticipation or reward outcome images due to any 
combinations of reasons including poor task performance, technical errors, or poor image 
quality. Hence, for the dysregulated group there were 195 participants with both reward 
anticipation and reward outcome images. 
From the starting N=233 dysregulated participants with an anatomical scan, 231 received 
a face processing scan. The reasons for missingness in those two are unknown but are likely due 
to the participant electing to stop, scheduling conflicts, or scanner malfunctions. Of those 231, 
there was one participant excluded due to excessive head motion. Of the remaining 230, there 
were 26 who did not provide any of the face processing contrast images due to any combinations 
of reasons including technical errors, or poor image quality. As this is a passive viewing task, 
behavioral performance quality control is not applicable. Hence, for the dysregulated group there 
were 204 participants with all face processing contrast images. See Table S3 for a breakdown of 
all fMRI contrast image sample sizes by group. 
 
Low Symptom Group Missingness 
From the starting N=233 low symptom participants with an anatomical scan, 228 
received a stop signal task scan. The reasons for missingness in those five are unknown but are 
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likely due to the participant electing to stop, scheduling conflicts, or scanner malfunctions. No 
participants were excluded due to head motion. Of those 228, here were 34 participants who did 
not provide stop success images and 31 participants who did not provide stop failure images. 
Reasons for missing these contrast images may be due to any combination of reasons including 
poor task performance, technical errors, or poor image quality. Hence, for the low symptom 
group there were 194 participants with stop success images and 197 participants with stop failure 
images. 
From the starting N=233 low symptom participants with an anatomical scan, 217 
received a reward task scan. The reasons for missingness in those 16 are unknown but are likely 
due to the participant electing to stop, scheduling conflicts, or scanner malfunctions. Of those 
217, there was one participant excluded due to excessive head motion. Of the remaining 216, 
there were 26 who did not provide either reward anticipation or reward outcome images due to 
any combinations of reasons including poor task performance, technical errors, or poor image 
quality. Hence, for the low symptom group there were 190 participants with both reward 
anticipation and reward outcome images. 
From the starting N=233 low symptom participants with an anatomical scan, all 233 
received a face processing scan and none were excluded due to head motion. Of those 233, there 
were 30 who did not provide any of the face processing contrast images due to any combinations 
of reasons including technical errors, or poor image quality. As this is a passive viewing task, 
behavioral performance quality control is not applicable. Hence, for the low symptom group 
there were 203 participants with all face processing contrast images. See Table S3 for a 
breakdown of all fMRI contrast image sample sizes by group. 
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Additional Analyses 
Balancing of Site  
While the dysregulated and low symptom groups were best matched on site, we tested 
whether any non-significant differences in site may have influenced the findings. To do so, we 
randomly sampled without replacement to perfectly balance the two groups on each site. From 
the starting n=466, a random sample of n=408 was identified (n=204 for each group), such that 
each group had a perfectly balanced representation from each of the eight sites. A two-sample t-
test yielded consistent findings with the original sample, such that lower GMV was found in the 
dysregulated group (t406 = -3.34, p < .001). Therefore, we do not suspect the non-significant 
difference in site distribution to be driving the overall finding of the paper. 
 
Random Subsampling Test to Balance Head Motion  
 
While head motion estimates were accounted for in the first-level contrast image 
estimation, and, again as a nuisance covariate (mean FD) in the between group comparison, we 
note that the dysregulated group had significantly higher head motion than the low symptom 
group, and partialling out these differences does not negate the significant difference. To assess 
whether head motion was driving the between-group differences for stop success, a random 
subsampling procedure was implemented. Here, we identified two random subsamples of the 
dysregulated and low symptom group who failed to differ on head motion. To do this, we 
randomly sampled without replacement 80% of the dysregulated sample, and 83% of the low 
symptom. These percentages were chosen to use consistent subsample rates of the fMRI data 
relative to the anatomical data (See Table S3).  
A random subsample of n=149 dysregulated and n=161 low symptom participants were 
selected until a two-sample t-test failed to identify between-group head motion differences (p > 
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.05). Next, these pseudo-random subsamples were submitted to a similar ANCOVA model, 
regressing the stop success activations against the two groups, accounting for head motion (mean 
FD). This procedure was performed 5,000 times, while saving the F- and p-value of the 
dysregulation status coefficient (the between-subject effect). This procedure resulted in a mean 
F1,307=4.9, p=.045. As consistent effects were found on these pseudo-random samples, these 
results indicate that the between-group differences in stop success activation persist after 
effectively removing the differences in head motion.   
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Table S1: Dysregulated Class Participants Compared to All Other Latent Class Analysis Participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Comparison of participant characteristics for those identified from the latent class analysis. The 
dysregulation class (Class 3) compared to the individuals from all other classes. Relative to main text 
Table 2, there were three dysregulated participants and nine other class participants with incomplete 
demographic information.  
 
 
Table S2: Dysregulated and Low Symptoms Group Characteristics 
 
Note: Dysregulated individuals identified from a latent class of respondents most likely to endorse 
problems related to prosocial behaviors, attention, positive affect, and conduct. The comparison group 
(“low symptoms”) were identified from a latent class of respondents who were least likely to endorse 
similar problems, and randomly sampled until a subsample of individuals failed to exhibit between-group 
differences on sex, age, performance and verbal IQ, pubertal development, total gray matter volume, and 
handedness. Total Gray Matter Volume was calculated from the whole-brain VBM image. All other 
tabulated features were calculated from self-report measures, with IQs measured via the Weschler 
Intelligence scale and Pubertal Development measured via the PDS (described above). The PDS measure 
is an average score (from 0-4) across five items detailing physiological changes in males and females 
separately. 
 
Measure 
Group  
p Dysregulation 
(N=258) 
All Other Groups 
(N=1856) 
Sex (Male, Female) 146, 112 887, 969 .01 
Age in years (M, SD) 14.56, .43 14.55, .44 .50 
Performance IQ (M, SD) 103.59, 13.97 108.01, 13.64 .01 
Verbal IQ (M, SD) 106.83, 14.38 111.37, 13.56 .01 
Pubertal Development (M, SD) 2.83, .55 2.92, .56 .01 
Handedness (Right, Left) 235, 23 1669, 187 .56 
    
London (N) 29 240 .42 
Nottingham (N) 41 246 .27 
Dublin (N) 32 203 .51 
Berlin (N) 38 230 .31 
Hamburg (N) 32 234 .90 
Mannheim (N) 25 239 .14 
Paris (N) 31 232 .80 
Dresden (N) 30 232 .66 
 
 
Measure 
Groups  
p Dysregulation (N=233) Low Symptoms (N=233) 
Sex (Male, Female) 127,106 127,106 1.00 
Age in years (M, SD) 14.58, .45 14.55, .45 .60 
Performance IQ (M, SD) 103.48, 14.56 103.20, 12.70 .82 
Verbal IQ (M, SD) 106.34, 14.88 106.85, 11.70 .69 
Pubertal Development (M, SD) 2.82, .54 2.86, .57 .42 
Total Gray Matter Volume mm3 (M, SD) 729.92, 69.56 737.56, 65.35 .18 
Handedness (Right, Left) (212, 22) (211, 21) .87 
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Table S3: Outline of Samples Used for Each fMRI Comparison 
 
Note: Only participants who received the fMRI scan were considered as candidates for lost data, hence, 
the analytic and lost sample sizes may not sum to the 233 that received an anatomical scan. 
 
 
 
 
 
 
Table S4: Analysis of Head Motion in Reduced Samples with fMRI data 
 
 
Note: MID = Monetary Incentive Delay Task. 
 
 
fMRI Contrast 
Dysregulated Class Low Symptom Class 
Analytic Sample  
N, % 
Lost Sample 
N, % 
Analytic Sample  
N, % 
Lost Sample  
N, % 
Stop Success 186 (.80) 37 (.16) 194 (.83) 34 (.15) 
Stop Fail 195 (.84) 28 (.12) 197 (.85) 31 (.13) 
   
Neutral Faces 204 (.88) 26 (.11) 203 (.87) 30 (.13) 
Angry Faces 204 (.88) 26 (.11) 203 (.87) 30 (.13) 
Angry-Neutral Faces 204 (.88) 26 (.11) 203 (.87) 30 (.13) 
   
Reward Anticipation 195 (.84) 22 (.09) 190 (.82) 26 (.11) 
Reward Outcome 195 (.84) 22 (.09) 190 (.82)  26 (.11) 
 
 
Task 
Framewise Displacement  
 
Dysregulated vs. Low Symptom Dysregulation Group Low Symptom Group 
N M SD N M SD 
Stop Signal 186 .14 .10 194 .11 .08 t378= 2.9, p < .05 
Faces 204 .13 .12 203 .10 .08 t405= 2.7, p < .05 
MID 195 .18 .14 190 .14 .11 t383= 3.1, p < .05 
